Altimmune, Inc. (ALT) shares are declining more than 8 percent on Monday morning, as the stock is in search of new support.
Currently, the shares are at $9.16, down 9.58 percent from its previous close of $10.13. For the 52-week period, the shares have traded in a range of $1.51 to $35.10 on average volume of 1,646,232. The clinical-stage biopharmaceutical company stock had closed below 8.00 on November 9 on more than average volume.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.